802 related articles for article (PubMed ID: 33033392)
1. The four epidemiological stages in the global evolution of inflammatory bowel disease.
Kaplan GG; Windsor JW
Nat Rev Gastroenterol Hepatol; 2021 Jan; 18(1):56-66. PubMed ID: 33033392
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.
Kaplan GG; Bernstein CN; Coward S; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S6-S16. PubMed ID: 31294381
[TBL] [Abstract][Full Text] [Related]
3. Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic.
El Ouali S; Rubin DT; Cohen BL; Regueiro MD; Rieder F
Curr Opin Gastroenterol; 2021 Jul; 37(4):313-319. PubMed ID: 33859104
[TBL] [Abstract][Full Text] [Related]
4. Social media in inflammatory bowel disease: the patient and physician perspective.
Ahmed W; Taft TH; Charabaty A
Curr Opin Gastroenterol; 2021 Jul; 37(4):328-335. PubMed ID: 33859103
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
Bekic D; Belosic Halle Z
Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
[TBL] [Abstract][Full Text] [Related]
6. Changing epidemiology of inflammatory bowel disease in children and adolescents.
Long D; Wang C; Huang Y; Mao C; Xu Y; Zhu Y
Int J Colorectal Dis; 2024 May; 39(1):73. PubMed ID: 38760622
[TBL] [Abstract][Full Text] [Related]
7. The global burden of IBD: from 2015 to 2025.
Kaplan GG
Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):720-7. PubMed ID: 26323879
[TBL] [Abstract][Full Text] [Related]
8. A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.
Di Ruscio M; Lunardi G; Buonfrate D; Gobbi F; Bertoli G; Piccoli D; Conti A; Geccherle A; Variola A
Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684085
[No Abstract] [Full Text] [Related]
9. Cost concerns, not the guidelines, drive clinical care of IBD during COVID pandemic in a resource limited setting.
Sharma V; Shukla J; Suri V; Jena A; Mukerjee A; Mandavdhare HS; Bhalla A; Dutta U
Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):465-466. PubMed ID: 33576700
[No Abstract] [Full Text] [Related]
10. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
[TBL] [Abstract][Full Text] [Related]
11. What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?
Taxonera C; Alba C; Olivares D
Gastroenterology; 2021 Apr; 160(5):1901-1902. PubMed ID: 32687925
[No Abstract] [Full Text] [Related]
12. Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.
Scucchi L; Neri B; Sarmati L; Mossa M; Sena G; Massoud R; Petruzziello C; Musumeci M; Marafini I; Calabrese E; Lolli E; Bernardini S; Andreoni M; Monteleone G; Biancone L
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2418-2424. PubMed ID: 33755981
[TBL] [Abstract][Full Text] [Related]
13. Evolving Epidemiology of IBD.
Windsor JW; Kaplan GG
Curr Gastroenterol Rep; 2019 Jul; 21(8):40. PubMed ID: 31338613
[TBL] [Abstract][Full Text] [Related]
14. 2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases.
Taxonera C; Sagastagoitia I; Alba C; Mañas N; Olivares D; Rey E
Aliment Pharmacol Ther; 2020 Jul; 52(2):276-283. PubMed ID: 32359205
[TBL] [Abstract][Full Text] [Related]
15. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.
Kaplan GG; Ng SC
Gastroenterology; 2017 Feb; 152(2):313-321.e2. PubMed ID: 27793607
[TBL] [Abstract][Full Text] [Related]
16. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
[TBL] [Abstract][Full Text] [Related]
17. Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.
Szilagyi A; Xue X
Med Hypotheses; 2018 Jan; 110():31-37. PubMed ID: 29317064
[TBL] [Abstract][Full Text] [Related]
18. Providing Guidance During a Global Viral Pandemic for the Care of Patients With Inflammatory Bowel Disease.
Abreu MT; Peyrin-Biroulet L
J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S767-S768. PubMed ID: 33085969
[No Abstract] [Full Text] [Related]
19. Inflammatory bowel disease: estimates from the global burden of disease 2017 study.
Piovani D; Danese S; Peyrin-Biroulet L; Bonovas S
Aliment Pharmacol Ther; 2020 Jan; 51(2):261-270. PubMed ID: 31660629
[TBL] [Abstract][Full Text] [Related]
20. Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey.
Cheema M; Mitrev N; Hall L; Tiongson M; Ahlenstiel G; Kariyawasam V
BMJ Open Gastroenterol; 2021 Feb; 8(1):. PubMed ID: 33579729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
